Novo Nordisk has named Maziar Mike Doustdar as its new president and chief executive officer. He will take over the role on 7 August 2025, replacing Lars Fruergaard Jørgensen, who will step down the ...

Analysis - New evidence shows how JAS' Shiroro cell adopts a flexible approach that tolerates local bandits and their vices.